Related Experiment Video
Updated: Apr 28, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
The genetic and biochemical basis of FANCD2 monoubiquitination
Eeson Rajendra1, Vibe H Oestergaard1, Frédéric Langevin1
1MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Abstract:
Fanconi anaemia (FA) is a cancer predisposition syndrome characterized by cellular sensitivity to DNA interstrand crosslinkers. The molecular defect in FA is an impaired DNA repair pathway. The critical event in activating this pathway is monoubiquitination of FANCD2. In vivo, a multisubunit FA core complex catalyzes this step, but its mechanism is unclear. Here, we report purification of a native avian FA core complex and biochemical reconstitution of FANCD2 monoubiquitination. This demonstrates that the catalytic FANCL E3 ligase subunit must be embedded within the complex for maximal activity and site specificity. We genetically and biochemically define a minimal subcomplex comprising just three proteins (FANCB, FANCL, and FAAP100) that functions as the monoubiquitination module. Residual FANCD2 monoubiquitination activity is retained in cells defective for other FA core complex subunits. This work describes the in vitro reconstitution and characterization of this multisubunit monoubiquitin E3 ligase, providing key insight into the conserved FA DNA repair pathway.
Insights
Fanconi anaemia (FA) is a cancer syndrome linked to DNA repair defects. Researchers reconstituted the FA core complex in vitro, identifying a minimal three-protein module essential for FANCD2 monoubiquitination and DNA repair.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Fanconi anaemia (FA) is a rare genetic disorder characterized by bone marrow failure and a high risk of cancer.
- Cellular sensitivity to DNA interstrand crosslinkers is a hallmark of FA, stemming from defects in a complex DNA repair pathway.
- The Fanconi anaemia core complex is crucial for activating this repair pathway through the monoubiquitination of the FANCD2 protein, but its precise mechanism remains elusive.
Purpose of the Study:
- To elucidate the mechanism of FANCD2 monoubiquitination by the Fanconi anaemia core complex.
- To identify the minimal subunit composition required for the catalytic activity of the FA core complex.
- To biochemically reconstitute and characterize the FA core complex's E3 ligase activity in vitro.
Main Methods:
- Purification of a native avian Fanconi anaemia core complex.
- Biochemical reconstitution assays to study FANCD2 monoubiquitination.
- Genetic and biochemical characterization of FA core complex subunits and subcomplexes.
Main Results:
- The catalytic FANCL E3 ligase subunit must be integrated within the FA core complex for optimal activity and specificity.
- A minimal three-protein subcomplex (FANCB, FANCL, FAAP100) was identified as the core monoubiquitination module.
- FANCD2 monoubiquitination activity was still observed in cells lacking other FA core complex subunits, suggesting functional redundancy or alternative activation mechanisms.
Conclusions:
- The study successfully reconstituted the Fanconi anaemia core complex's E3 ligase activity in vitro, providing critical mechanistic insights.
- The identification of a minimal functional subcomplex advances our understanding of the FA DNA repair pathway.
- This research contributes to understanding the molecular basis of Fanconi anaemia and related DNA repair processes.
More Related Videos
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Pharmacogenomics: Identification of New Drug Targets
Centrosome Duplication
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...

